Ethyl cis-4-Aminocyclohexanecarboxylate Hydrochloride is used as a reagent in the synthesis of arylpiperazinylalkyl and arylpiperazinylalkylthio quinazolinones as dual 5-HT1a agonists and 5-HT3 antagonists for use in treating irritable bowel syndrome (IBS).
